Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Quality of Life

Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation

Abstract

Patient/caregiver out-of pocket costs associated with hematopoietic cell transplantation (HCT) are not well known. We conducted a pilot study to evaluate patient/caregiver out-of-pocket costs in the first 3 months after allogeneic HCT. Thirty patients were enrolled at three sites. Before HCT, participants completed a baseline survey regarding household income and insurance coverage. Subsequently, they maintained a paper-based diary to track daily out-of-pocket expenses for the first 3 months after HCT. Telephone interviews were conducted to follow-up on the missing/incomplete diaries and on study completion. Twenty-five patients/caregivers completed the baseline survey. Among these, the median pre-tax household income was $66 500 (range, $30–$375 000) and 48% had to temporarily relocate close to the transplant center. Insurance coverage was managed care plan (56%), Medicaid (20%), Medicare (17%) and other (8%). Twenty-two patients/caregivers completed 4 diaries; the median out-of-pocket expenses were $2440 (range, $199–$13 769). Patients/caregivers who required temporary lodging had higher out-of-pocket expenses compared with those who did not (median, $5247 vs $716). Patients/caregivers can incur substantial out-of-pocket costs over the first 3 months, especially if they need to temporarily relocate close to the transplant center. Our study lays the foundation for future research on the early and long-term financial impact of allogeneic HCT on patients/caregivers.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Preussler JM, Denzen EM, Majhail NS . Costs and cost-effectiveness of hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012; 18: 1620–1628.

    Article  Google Scholar 

  2. Lee SJ, Klar N, Weeks JC, Antin JH . Predicting costs of stem-cell transplantation. J Clin Oncol 2000; 18: 64–71.

    Article  CAS  Google Scholar 

  3. Majhail NS, Mothukuri JM, Brunstein CG, Weisdorf DJ . Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications. Biol Blood Marrow Transplant 2009; 15: 564–573.

    Article  Google Scholar 

  4. Majhail NS, Mothukuri JM, Macmillan ML, Verneris MR, Orchard PJ, Wagner JE et al. Costs of pediatric allogeneic hematopoietic-cell transplantation. Pediatr Blood Cancer 2010; 54: 138–143.

    Article  Google Scholar 

  5. Saito AM, Cutler C, Zahrieh D, Soiffer RJ, Ho VT, Alyea EP et al. Costs of allogeneic hematopoietic cell transplantation with high-dose regimens. Biol Blood Marrow Transplant 2008; 14: 197–207.

    Article  Google Scholar 

  6. Saito AM, Zahrieh D, Cutler C, Ho VT, Antin JH, Soiffer RJ et al. Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy. Bone Marrow Transplant 2007; 40: 209–217.

    Article  CAS  Google Scholar 

  7. Stranges E, Russo CA, Friedman B . Procedures with the most rapidly increasing hospital costs, 2004–2007. HCUP Statistical Brief #82. Agency for Healthcare Research and Quality: Rockville, MDhttp://www.hcup-us.ahrq.gov/reports/statbriefs/sb82.pdf2009.

    Google Scholar 

  8. Khera N, Zeliadt SB, Lee SJ . Economics of hematopoietic cell transplantation. Blood 2012; 120: 1545–1551.

    Article  CAS  Google Scholar 

  9. Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 2009; 27: 3868–3874.

    Article  Google Scholar 

  10. Wagner L, Lacey MD . The hidden costs of cancer care: an overview with implications and referral resources for oncology nurses. Clin J Oncol Nurs 2004; 8: 279–287.

    Article  Google Scholar 

  11. Kim P . Cost of cancer care: the patient perspective. J Clin Oncol 2007; 25: 228–232.

    Article  Google Scholar 

  12. Meehan KR, Fitzmaurice T, Root L, Kimtis E, Patchett L, Hill J . The financial requirements and time commitments of caregivers for autologous stem cell transplant recipients. J Support Oncol 2006; 4: 187–190.

    PubMed  Google Scholar 

  13. Frey P, Stinson T, Siston A, Knight SJ, Ferdman E, Traynor A et al. Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program. Bone Marrow Transplant 2002; 30: 741–748.

    Article  CAS  Google Scholar 

  14. Rizzo JD, Vogelsang GB, Krumm S, Frink B, Mock V, Bass EB . Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting? J Clin Oncol 1999; 17: 2811–2818.

    Article  CAS  Google Scholar 

  15. Cohn RJ, Goodenough B, Foreman T, Suneson J . Hidden financial costs in treatment for childhood cancer: an Australian study of lifestyle implications for families absorbing out-of-pocket expenses. J Pediatr Hematol Oncol 2003; 25: 854–863.

    Article  Google Scholar 

  16. Goossens ME, Rutten-van Molken MP, Vlaeyen JW, van der Linden SM . The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000; 53: 688–695.

    Article  CAS  Google Scholar 

  17. Eiser C, Upton P . Costs of caring for a child with cancer: a questionnaire survey. Child Care Health Dev 2007; 33: 455–459.

    Article  CAS  Google Scholar 

  18. Longo CJ, Deber R, Fitch M, Williams AP, D'Souza D . An examination of cancer patients' monthly 'out-of-pocket' costs in Ontario, Canada. Eur J Cancer Care 2007; 16: 500–507.

    Article  CAS  Google Scholar 

  19. Longo CJ, Fitch M, Deber RB, Williams AP . Financial and family burden associated with cancer treatment in Ontario, Canada. Support Care Cancer 2006; 14: 1077–1085.

    Article  Google Scholar 

  20. Pope C, Ziebland S, Mays N . Qualitative research in health care. Analysing qualitative data. BMJ 2000; 320: 114–116.

    Article  CAS  Google Scholar 

  21. Burnard P . A method of analysing interview transcripts in qualitative research. Nurse Educ Today 1991; 11: 461–466.

    Article  CAS  Google Scholar 

  22. Krueger RA, Casey MA . Focus groups: A practical guide for applied research. 3rd edn. Sage Publications: Thousand Oaks, CA, 2009.

    Google Scholar 

  23. Majhail NS, Omondi NA, Denzen E, Murphy EA, Rizzo JD . Access to hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant 2010; 16: 1070–1075.

    Article  Google Scholar 

Download references

Acknowledgements

We acknowledge the contribution of Tammy Payton, National Marrow Donor Program Patient Services department, in assisting with the analysis of qualitative data. We thank the study coordinators at the Medical College of Wisconsin (Leigh Ann Laczkowski), the Roswell Park Cancer Institute (Dana Cipolla, Lise Hernandez) and the University of Minnesota (Jenna Johnson, Becky Draxler) for their help in enrolling patients on the study. The National Marrow Donor Program provided funding for gift cards for study participants. The Center for International Blood and Marrow Transplant Research is supported by Public Health Service Grant/Cooperative Agreement U24-CA76518 from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID); a Grant/Cooperative Agreement 5U01HL069294 from NHLBI and NCI; a contract HHSH234200637015C with Health Resources and Services Administration (HRSA/DHHS); two Grants N00014-06-1-0704 and N00014-08-1-0058 from the Office of Naval Research; and grants from AABB; Allos, Inc.; Amgen, Inc.; Anonymous donation to the Medical College of Wisconsin; Astellas Pharma US, Inc.; Be the Match Foundation; Biogen IDEC; BioMarin Pharmaceutical, Inc.; Biovitrum AB; BloodCenter of Wisconsin; Blue Cross and Blue Shield Association; Bone Marrow Foundation; Buchanan Family Foundation; CaridianBCT; Celgene Corporation; CellGenix, GmbH; Children’s Leukemia Research Association; ClinImmune Labs; CTI Clinical Trial and Consulting Services; Eisai, Inc.; Genentech, Inc.; Genzyme Corporation; Histogenetics, Inc.; HKS Medical Information Systems; Hospira, Inc.; Kirin Brewery Co., Ltd.; The Leukemia & Lymphoma Society; Merck & Company; The Medical College of Wisconsin; Millennium Pharmaceuticals, Inc.; Miller Pharmacal Group; Milliman USA, Inc.; Miltenyi Biotec, Inc.; National Marrow Donor Program; Nature Publishing Group; Novartis Oncology; Oncology Nursing Society; Osiris Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; Pall Life Sciences; Pfizer Inc; Schering Corporation; Sigma-Tau Pharmaceuticals; Soligenix, Inc.; StemCyte, Inc.; StemSoft Software, Inc.; Sysmex America, Inc.; THERAKOS, Inc.; Vidacare Corporation; ViraCor Laboratories; ViroPharma, Inc.; and Wellpoint, Inc. The views expressed in this article do not reflect the official policy or position of the National Institutes of Health, the Department of the Navy, the Department of Defense, or any other agency of the US Government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N S Majhail.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Bone Marrow Transplantation website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Majhail, N., Rizzo, J., Hahn, T. et al. Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 48, 865–871 (2013). https://doi.org/10.1038/bmt.2012.248

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2012.248

Keywords

This article is cited by

Search

Quick links